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Abstract
Transcranial magnetic stimulation (TMS) is used both as a diagnostic instrument and 
for therapy, available only at some psychiatric clinics for treatment of depression and at 
clinical neurophysiology where TMS is used for diagnosis of nerve damage. The Swedish 
National Board of Health and Welfare issued a referral edition about the use of repetitive 
TMS as an alternative treatment for depression. This may lead to a major increase in the 
application of TMS to treat depression. TMS is based on induction of an electric (E) field 
inside the brain by application of an external magnetic field with rapid rise and fall time. 
The E field in the brain has been calculated when different coils were used for the treat-
ment. The reported E fields are of the order of tens to hundreds of volts per meter and the 
induced current density is estimated at tens of A/m2. This field can depolarize neurons or 
modulate cortical excitability by selecting the appropriate parameters for stimulation and 
the duration of the treatment session. The mechanisms of action of neurostimulation still 
remain incompletely understood.
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1. Introduction
Transcranial magnetic stimulation (TMS) is used primarily in research and treatments of cen-
tral nervous diseases, such as recurrent depressions, and has been used for several years. 
The non-invasive stimulation of the cortical cortex is accomplished through the application 
of pulsed magnetic fields generated by coils in different arrangements. The effects on major 
depressive disorder in adults have been reviewed by Perera et al. [1] and the Clinical TMS 
society, and they state that following the clinical recommendations given in their document it 
should result in continued safe and effective use of the TMS.
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However, it is not yet so widespread, and today in Sweden and Norway, TMS equipment is 
available only at some psychiatric clinics for treatment of depression and at clinical neuro-
physiology where TMS is used for diagnosis of nerve damage. The Swedish National Board 
of Health and Welfare has issued a referral edition about the use of repetitive TMS as an 
alternative treatment for depression. The method is new, but it has been used with positive 
effects on persons with medium-to-severe depression. This may lead to a major increase in the 
application of TMS to treat depression.
However, although TMS have been reviewed several times, the potential exposure to the ther-
apeutic staff has been neglected. The magnetic pulses can be targeted to selected cortical areas 
through the design and placement of the different coils used.
Occupational exposure limits have been recently revised in Europe and are given in the new 
EU directive [2] and the ICNIRP guidelines [3]. For the exposure experienced during TMS 
treatment, the limits are set to avoid stimulation of nerves. Studies by Karlström et al. [4] and 
Möllerlökken et al. [5] investigated the therapeutic staff exposure to pulsed magnetic fields 
during TMS/rTMS treatments in relation to the occupational exposure limits given and found 
that these limits may be exceeded close to the coil and safety measures are needed. In this 
paper, we will look closer into this exposure.
2. Different coil design
The magnetic pulses can be targeted to selected cortical areas through the design and 
placement of the different coils used. Lu and Ueno [6] have recently reviewed different coil 
configurations and how the induced electric field in the brain is distributed. Figure 1 from 
their publication shows some of the most common designs. Most commonly used is a pair 
of coils arranged in the form of the figure-8. The pulsed magnetic field will induce elec-
tric currents in the cerebral tissue, and the effect will be strongest in the areas close to the 
coil. The treatment is non-invasive and therefore to prefer compared to electro-convulsion 
therapy.
2.1. Measurement
Figure 2 shows a typical position of a patient receiving treatment with a figure-8 coil posi-
tioned with a fixed position on the head.
The current in the coils can reach some kA in strength and the waveform is sinusoidal with 
frequency around some kHz. The magnetic flux density generated by TMS equipment can 
reach the order of 1 Tesla. Since the duration is only about 0.05–0.4 ms, this give rise to a time 
derivative of the field of the order of tens of kT/s. This then induce an electric field in the tissue 
that can reach the threshold for localized axonal depolarization of more than 100 V/m. For fur-
ther information on this, we refer the reader to Deng et al. [7], Bottauscio et al. [8] and Lu and 
Ueno [6]. Since the limit for occupational exposure for the frequencies used in TMS is around 
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1 V/m, it is not surprising that staff can be at risk for overexposure if working too close to the 
coil when in use. This is something they often need to be because either the coil moves out of 
position or the patient needs assistance. In addition, many of the coils are designed so that the 
trigger-button for the pulse is placed on the coil itself. This button is used in the beginning of 
the treatment sequence to establish what power is needed to place the coil in the correct posi-
tion. Such work makes it impossible for the operator to not be in close contact with the coil 
and therefore in risk of overexposure.
We have measured the magnetic field from some TMS machines. We used a system with an 
electrically shielded circular coil with 2.5 cm radius, calibrated. The induced voltage was 
Figure 1. Realistic head model with coils. (a) Double cone coil, (b) H-coil, (c) HCA coil, and (d) Figure-8 coil. Reproduced 
from Lu and Ueno [6] with permission.
Figure 2. Position of a “patient” received TMS treatment with a figure-8 coil. The schematic drawing shows the induced 
electric field in tissue. Photo: Kjell Hansson Mild, drawing courtesy of Shoogo Ueno, Tokyo.
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registered with a Tektronix TDS 1012 digital storage oscilloscope. With this equipment, we 
pick up the time derivate of the magnetic field, dB/dt. An example of the single pulse can 
be seen in Figure 3. Figure 4 gives an example of the series of pulses delivered in treatment 
sessions.
The system we have looked at is: MagVenture rTMS system with a magnetic coil type Cool-B65 
(MagVenture A/S, Inc., USA). The Cool-B65 coil is a figure-8 coil with partially overlapping 
coils, and a MegPro unit with a magnetic coil transducer model, and MC-B70 (Medtronic 
Synectics AB, P.O. Box 265, SE-177 25 Järfälla, Sweden; http://www.synectics.se).
At some distance, depending on power setting and coil design, the distance from the coil 
where the action levels of the EU directive are exceeded is from some decimeter to almost 
a full meter. For the MagVenture system, the limit distance was 0.4 m and for the MegPro 
0.7 m.
In the EU guideline [9] for how to implement the new EU directive measurements and dis-
cussion about the TMS exposure to staff are given. They found that at a typical hand position 
Figure 3. Recording of dB/dt in a single pulse from the MagVenture system. The frequency of the pulse was found to be 
about 2.5 kHz and practically sinusoidal.
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holding the hand piece with the coil the magnetic flux density exceed by 5,600% the limit for 
the limb. The team realized that the clinician was highly likely to exceed the action levels, 
and therefore a computer model was applied. From the computer calculation of the induced 
electric field, they found that the exposure limits could be exceeded up to 35,700% with the 
coil 15 cm from the torso.
2.2. Implants
The magnetic field pulses can exert attractive forces on ferromagnetic objects and repulsive 
forces on non-ferromagnetic objects. Therefore, it is of importance to screen the patients before 
treatment for metallic objects, such as cochlear implants, and other implanted objects in the 
scalp, such as deep brain stimulators and epidural electrode arrays for cortical stimulation. 
According to a review by Rossi et al. [10], it appears that TMS can be safely applied to patients 
with implanted stimulators of CNS and PNS when the coil is not in close proximity to the 
internal pulse generator. However, the information about the safe use in these cases is sparse, 
and therefore Rossi et al. [10] state that TMS should only be done in patients with implanted 
stimulators if there are scientifically or medically compelling reasons justifying this.
Figure 4. The system can be set to deliver a single pulse or a series pulses. In the rTMS, a pulse train with 20 pulses within 
some second is repeated with a frequency of some Hz. This is then applied for up to 15 min per session.




It was clear from the measurements that the worker’s exposure limits for the magnetic field 
pulses are transgressed at distances of about 0.7 m from the surface of the transducer’s coils 
during normal patient treatment conditions. The coil handle, which is located in the plane of 
the figure-8 coils, is about 20 cm long, and this results in a short distance between the source 
of the field and the hand and forearm of the operator. The TMS transducer can in this case 
be seen as a single dipole with decay as the inverse of the cube of the distance, 1/r3. The head 
and trunk of the operator is at most an arm-length apart from the source, and since the basic 
restrictions are based on induced current in the head and the trunk for frequencies up to 
10 MHz [2, 3], limiting exposures to the head and trunk are necessary. Different designs of 
TMS devices should be further studied to bring deeper insight in the issue of at what distance 
the limits in terms of induced electric field on the staff are exceeded from the surface of the 
transducer’s coils during normal patient treatment conditions.
To avoid risks of overexposure to magnetic pulses, a recommendation that is valid for both 
single coil and figure-8 transducers, the equipment should be used with a mechanical arm 
holding the transducer in the right position for the patient. The staff operating the TMS equip-
ment need to be educated and trained to operate the equipment in a safe way. EU guide-
line also states [9] that it is necessary to prohibit pregnant workers and workers with active 
implanted medical devices (AIMD) from operating the equipment or remaining in the room 
during treatment. Treatment should not be given to patients fitted with AIMD.
Unnecessary over-exposure to pulsed magnetic fields of this magnitude may cause negative 
health effects for the therapeutic staff. From the exposure guidelines, it is known that the 
rationale for limiting exposure is the well-defined biological responses ranging from percep-
tion of the fields to annoyance and stimulation of central and peripheral nervous tissue. Our 
studies were not designed to investigate health effects among the therapeutic staff, this is 
needed in the future, and neither did we investigate other possible risk factors for health com-
plaints in this working environment, such as indoor climate, noise, and treatment lengths.
In conclusion, staff working with patient treatment with TMS/rTMS can become exposed to 
magnetic field levels exceeding both EU directive and ICNIRP guidelines; therefore, it is rec-
ommended that procedures are developed to avoid unnecessary exposure of staff. Information 
about the risks associated with the application of the strong magnetic pulses is necessary, and 
a training programme for the staff would be advisable.
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